Results from CAR T-cell bb2121 first-in-human trial for R/R MM

The anti-BCMA CAR T-cell therapy bb2121 looks extremely promising in multiple myeloma (MM). Here, Noopur Raje, MD, of Massachusetts General Hospital Cancer Center, Boston, MA, discusses the results of... Author: VJHemOnc Added: 07/30/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts